Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Precision Dosing of Infliximab Versus Conventional Dosing of Infliximab (PRECISION)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02453776
Recruitment Status : Unknown
Verified January 2016 by M. Lowenberg, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).
Recruitment status was:  Recruiting
First Posted : May 27, 2015
Last Update Posted : January 18, 2016
Sponsor:
Information provided by (Responsible Party):
M. Lowenberg, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : April 2016
  Estimated Study Completion Date : April 2017